1. Home
  2. HALO vs CSGP Comparison

HALO vs CSGP Comparison

Compare HALO & CSGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$125.99

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Logo CoStar Group Inc.

CSGP

CoStar Group Inc.

HOLD

Current Price

$34.23

Market Cap

12.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HALO
CSGP
Founded
1998
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
12.9B
IPO Year
2001
1998

Fundamental Metrics

Financial Performance
Metric
HALO
CSGP
Price
$125.99
$34.23
Analyst Decision
Buy
Buy
Analyst Count
9
21
Target Price
★ $108.78
$37.40
AVG Volume (30 Days)
2.2M
★ 4.9M
Earning Date
11-05-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.11
0.14
Revenue
$151,862,000.00
★ $965,230,000.00
Revenue This Year
$34.69
$16.65
Revenue Next Year
$11.65
$11.16
P/E Ratio
★ $39.88
$251.46
Revenue Growth
N/A
★ 15.23
52 Week Low
$61.23
$25.89
52 Week High
$125.43
$79.07

Technical Indicators

Market Signals
Indicator
HALO
CSGP
Relative Strength Index (RSI) 74.21 66.95
Support Level $105.27 $33.32
Resistance Level N/A $34.84
Average True Range (ATR) 3.51 1.14
MACD 1.11 0.67
Stochastic Oscillator 99.04 83.39

Price Performance

Historical Comparison
HALO
CSGP

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CSGP CoStar Group Inc.

CoStar Group is a global provider of proprietary information, analytics, and online marketplaces serving both commercial and residential real estate. The firm operates through a diverse portfolio of brands, including CoStar Suite for commercial real estate research, LoopNet for commercial listings, Apartments.com for multifamily rentals, and Homes.com for residential brokerage. It primarily sells high-margin software-as-a-service subscriptions that provide institutional clients with forensic property data and premium advertising visibility. With operations across North America, Europe, and Asia-Pacific, CoStar maintains the industry's most comprehensive centralized real estate database, functioning as a critical information utility for brokers, lenders, and owners worldwide.

Share on Social Networks: